Europe Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)
The influenza vaccines market in Europe is expected to grow from US$ 2,261.85 million in 2022 to US$ 3,424.02 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2022 to 2028.
Increasing Investment by Top Market Players and Governments Boosts Europe Influenza Vaccines Market
Market players and governments worldwide are increasing their investments in vaccine development and immunization. For instance, in March 2021, Sanofi (Paris, France) announced an approximately US$ 925 million investment in a new vaccine manufacturing plant at its pre-existing site in Toronto, Canada. Investments in the new facility will provide additional antigen and filling capacity for Sanofi's FLUZONE high-dose quadrivalent influenza vaccines, increasing availability in Canada, the US, and Europe in the coming years. In April 2021, 3 levels of government—federal, provincial, and municipal—supported Sanofi Pasteur in building an "end-to-end" influenza vaccines factory in Toronto. The partners will invest ~US$ 1 billion to get the site up and running by 2027. Sanofi, for its part, will invest more than US$ 55 million, create 165 new eligible jobs, and maintain another 1,100. In addition, Sanofi will also invest ~US$ 79 million annually for 8 years to fund research and development in Canada.
In June 2021, The European Investment Bank signed a US$ 30.55 million global vaccine distribution agreement with biotech company Univercells to mass produce the COVID-19 vaccine at a new Belgian site. It helped build other vaccine factories across the world. In April 2022, the bank provided a US$ 15.27 million loan to IRBM, an Italian biomedical research company, to expand its vaccine production capacity and strengthen research on COVID-19 and other diseases. Thus, the increase in investment by top market players and governments across the region is bolstering the Europe influenza vaccines market.
Market Overview
Europe accounted for the second largest market owing to factors such as the rising geriatric population, increasing prevalence of flu and related illness, and growing demand for the development of new vaccines in the region. In addition, growing funding for research & development activities is likely to provide more opportunities in the coming years across the region.
Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
The Europe influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.
Based on vaccine type, the Europe influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.
Based on virus type, the Europe influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.
Based on technology, the Europe influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.
Based on route of administration, the Europe influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.
Based on target group, the Europe influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.
Based on country, the Europe influenza vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the market in 2022.
AstraZeneca; Emergent BioSolutions Inc.; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; Moderna, Inc.; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the influenza vaccines market in Europe.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Influenza Vaccines Market – By Vaccine Type
1.3.2 Europe Influenza Vaccines Market – By Virus Type
1.3.3 Europe Influenza Vaccines Market – By Technology
1.3.4 Europe Influenza Vaccines Market – By Route of Administration
1.3.5 Europe Influenza Vaccines Market – By Target Group
1.3.6 Europe Influenza Vaccines Market – By Country
2. Europe Influenza Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Influenza Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market –Europe Analysis
6.1 Europe Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 Europe Influenza Vaccines Market Revenue Forecasts And Analysis
6.2.1 Europe: Influenza Vaccines Market, 2019–2028 (US$ Million)
7. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type
7.1 Overview
7.2 Europe Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.2.1 Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Quadrivalent Vaccines : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Trivalent Vaccines : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type
8.1 Overview
8.2 Europe Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.2.1 Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology
9.1 Overview
9.2 Europe Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.2.1 Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.3 Egg-based
9.3.1 Overview
9.3.2 Egg-based : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Cell-Based : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration
10.1 Overview
10.2 Europe Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.2.1 Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
10.2.2 Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
10.3 Injection
10.3.1 Overview
10.3.2 Injection : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Nasal Spray: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group
11.1 Overview
11.2 Europe Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.2.1 Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
11.3 Infants
11.3.1 Overview
11.3.2 Infants : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Children: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Adults : Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Elderly People: Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. Europe Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis
12.1 Europe: Influenza Vaccines Market
12.1.1 Overview
12.1.2 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.1.2.1 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.2.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.2.1.5 Germany: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.2.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.2.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.2.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.2.2.5 UK: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.2.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.2.7 UK: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.2.3 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.2.3.4 France: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.2.3.5 France: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.2.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.3.7 France: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.2.4 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.1 Overview
12.1.2.4.2 Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.2.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.2.4.5 Italy: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.2.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.2.5 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.1 Overview
12.1.2.5.2 Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.2.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.2.5.5 Spain: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.2.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
12.1.2.6 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.1 Overview
12.1.2.6.2 Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)
12.1.2.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)
12.1.2.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)
12.1.2.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)
13. Europe Influenza Vaccine Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Moderna, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 SEQIRUS
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Emergent BioSolutions Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Mitsubishi Chemical Group Corporation
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Serum Institute of India Pvt. Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MYLAN N.V.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AstraZeneca
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Below are a few instances of companies and their pipeline products:
Table 2. Europe Influenza Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. Europe Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 7. Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 8. Germany Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 13. UK Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 17. UK Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 18. France Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. France Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 21. France Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 22. France Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 23. Italy Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 28. Spain Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)
Table 38. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 39. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 40. Glossary of Terms, Influenza Vaccines Market
LIST OF FIGURES
Figure 1. Europe Influenza Vaccines Market Segmentation
Figure 2. Europe Influenza Vaccines Market Segmentation, by Country
Figure 3. Europe Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Europe Influenza Vaccines Market
Figure 5. UK Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 9. Europe Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 10. Quadrivalent Vaccines: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Trivalent Vaccines: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 13. Influenza Virus Type A : Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 16. Egg-based: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Cell-Based: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 19. Injection: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Nasal Spray: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Europe Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 22. Infants : Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Children: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Adults: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Elderly People: Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)
Figure 27. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 28. Germany: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. UK: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. France: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies in the Influenza Vaccine Market, 2021-2028
- AstraZeneca
- Emergent BioSolutions Inc.
- GlaxoSmithKline plc.
- Mitsubishi Chemical Group Corporation
- Moderna, Inc.
- MYLAN N.V.
- Sanofi
- SEQIRUS
- Serum Institute of India Pvt. Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Influenza Vaccines Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe Influenza Vaccines Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.